Research into plant-based drugs and medicines is ongoing, with some studies exploring their therapeutic potential, including against drug-induced liver injury. The global market for botanical and plant-derived drugs is projected to reach $58.1 billion by 2030, driven by advancements in biotechnology and personalized medicine. Investments and breakthrough designations are also being made in the field, including a recent FDA designation for a plant-derived cannabis formula for pain treatment.